Crestanello Juan A, Doliba Nicolai M, Doliba Natalia M, Babsky Andriy M, Niborii Koki, Osbakken Mary D, Whitman Glenn J R
Division of Cardiothoracic Surgery, University of Maryland Medical System, Baltimore, Maryland, USA.
J Surg Res. 2002 Feb;102(2):221-8. doi: 10.1006/jsre.2001.6324.
Coenzyme Q10 (CoQ10) protects myocardium from ischemia-reperfusion (IR) injury as evidenced by improved recovery of mechanical function, ATP, and phosphocreatine during reperfusion. This protection may result from CoQ10's bioenergetic effects on the mitochondria, from its antioxidant properties, or both. The purpose of this study was to elucidate the effects of CoQ10 supplementation on mitochondrial function during myocardial ischemia-reperfusion using an isolated mitochondrial preparation.
Isolated hearts (n = 6/group) from rats pretreated with liposomal CoQ10 (10 mg/kg iv, CoQ10), vehicle (liposomal only, Vehicle), or saline (Saline) 30 min before the experiments were subjected to 15 min of equilibration (EQ), 25 min of ischemia (I), and 40 min of reperfusion (RP). Left ventricular-developed pressure (DP) was measured. Mitochondria were isolated at end-equilibration (end-EQ), at end-ischemia (end-I), and at end-reperfusion (end-RP). Mitochondrial respiratory function (State 2, 3, and 4, respiratory control index (RCI, ratio of State 3 to 4), and ADP:O ratio) was measured by polarography using NADH (alpha-ketoglutarate, alpha-KG)- or FADH (succinate, SA)-dependent substrates.
CoQ10 improved recovery of DP at end-RP (67 +/- 11% in CoQ10 vs 47 +/- 5% in Vehicle and 50 +/- 11% in Saline, P < 0.05 vs Vehicle and Saline). CoQ10 did not change preischemic mitochondrial function. IR decreased State 3 and RCI in all groups using either substrate. CoQ10 had no effect in the mitochondrial oxidation of alpha-KG at end-I. CoQ10 improved State 3 at end-I when SA was used (167 +/- 21 in CoQ10 vs 120 +/- 10 in Saline and 111 +/- 10 ng-atoms O/min/mg protein in Vehicle, P < 0.05). Using alpha-KG as a substrate, CoQ10 improved RCI at end-RP (4.2 +/- 0.2 in CoQ10 vs 3.2 +/- 0.2 in Saline and 3.0 +/- 0.3 in Vehicle, P < 0.05). Using SA, CoQ10 improved State 3 (181 +/- 10 in CoQ10 vs 142 +/- 9 in Saline and 140 +/- 12 ng-atoms O/min/mg protein in Vehicle, P < 0.05) and RCI (2.21 +/- 0.06 in CoQ10 vs 1.85 +/- 0.11 in Saline and 1.72 +/- 0.08 in Vehicle, P < 0.05) at end-RP.
The cardioprotective effects of CoQ10 can be attributed to the preservation of mitochondrial function during reperfusion as evidenced by improved FADH-dependent oxidation.
辅酶Q10(CoQ10)可保护心肌免受缺血再灌注(IR)损伤,这在再灌注期间机械功能、三磷酸腺苷(ATP)和磷酸肌酸的恢复改善中得到了证实。这种保护作用可能源于CoQ10对线粒体的生物能量学效应、其抗氧化特性或两者兼而有之。本研究的目的是使用分离的线粒体制剂阐明补充CoQ10对心肌缺血再灌注期间线粒体功能的影响。
在实验前30分钟,用脂质体CoQ10(10mg/kg静脉注射,CoQ10组)、赋形剂(仅脂质体,赋形剂组)或生理盐水(生理盐水组)预处理大鼠,然后分离心脏(每组n = 6),使其经历15分钟的平衡期(EQ)、25分钟的缺血期(I)和40分钟的再灌注期(RP)。测量左心室发展压(DP)。在平衡期末(end-EQ)、缺血期末(end-I)和再灌注期末(end-RP)分离线粒体。使用依赖烟酰胺腺嘌呤二核苷酸(NADH)(α-酮戊二酸,α-KG)或黄素腺嘌呤二核苷酸(FADH)(琥珀酸,SA)的底物,通过极谱法测量线粒体呼吸功能(状态2、3和4、呼吸控制指数(RCI,状态3与状态4的比值)和ADP:O比值)。
CoQ10组在再灌注期末DP的恢复情况得到改善(CoQ10组为67±11%,赋形剂组为47±5%,生理盐水组为50±11%,与赋形剂组和生理盐水组相比,P < 0.05)。CoQ10对缺血前的线粒体功能没有影响。在所有组中,IR均降低了使用任一底物时的状态3和RCI。CoQ10对缺血期末α-KG的线粒体氧化没有影响。当使用SA时,CoQ10在缺血期末改善了状态3(CoQ10组为167±21,生理盐水组为120±10,赋形剂组为111±10纳摩尔原子氧/分钟/毫克蛋白,P < 0.05)。以α-KG为底物时,CoQ10在再灌注期末改善了RCI(CoQ10组为4.2±0.2,生理盐水组为3.2±0.2,赋形剂组为3.0±0.3,P < 0.05)。使用SA时,CoQ10在再灌注期末改善了状态3(CoQ10组为181±10,生理盐水组为142±9,赋形剂组为140±12纳摩尔原子氧/分钟/毫克蛋白,P < 0.05)和RCI(CoQ10组为2.21±0.06,生理盐水组为1.85±0.11,赋形剂组为1.72±0.08,P < 0.05)。
CoQ10的心脏保护作用可归因于再灌注期间线粒体功能的保存,这在依赖FADH的氧化改善中得到了证实。